D18.01
Hemangioma of skin and subcutaneous tissue
Clinical Classification Guidelines
Medical Intelligence & Overview
Hemangiomas are common benign growths composed of a cluster of blood vessels. When these growths appear on the skin or just beneath it, they are termed hemangiomas of the skin and subcutaneous tissue. Typically, they are noticeable at birth or develop shortly after and may change in size or appearance over time. Most hemangiomas are harmless and may regress without treatment, but understanding their nature can help in managing them optimally.
Causes & Symptoms
Clinical Causes: The exact cause of hemangiomas is not fully understood. They are believed to result from an abnormal proliferation of blood vessel cells during early fetal development. Genetic factors may play a role, as they sometimes run in families. Environmental influences are not clearly linked to the development of hemangiomas.
Key Symptoms: A bright red, purple, or blue slightly raised lump on the skin Growth that can rapidly increase in size during infancy Soft and compressible feel to the touch Potential ulceration or bleeding if the hemangioma is disturbed or injured In some cases, hemangiomas can interfere with vision, breathing, or feeding if located near important structures
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a physical examination where the healthcare provider assesses the appearance and growth pattern of the lesion. In some cases, imaging techniques such as ultrasound, MRI, or Doppler studies may be used to evaluate the depth and blood flow of the lesion, especially if the hemangioma is large or located internally. A biopsy is rarely necessary but may be performed if there is suspicion of other vascular anomalies or malignancies.
Treatment Protocols: Many hemangiomas require no treatment and will resolve naturally over time. However, when intervention is necessary, options may include: - **Observation**: Monitoring for spontaneous involution, especially for small or non-problematic hemangiomas. - **Medications**: Beta-blockers like propranolol have become a common treatment to reduce the size and coloration. - **Laser therapy**: Used to minimize redness or treat ulcerated areas. - **Surgical removal**: Reserved for large, problematic, or residual hemangiomas that do not regress or cause functional issues. It is important for individuals with hemangiomas to have regular follow-up appointments to assess the lesion’s progress and determine the need for ongoing care.
Clinical Advice & FAQs
Billing Guidance
Is D18.01 a billable ICD-10 code?
Yes, D18.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D18.01?
Clinical documentation must specify the nature of Hemangioma of skin and subcutaneous tissue and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
